This is an academic paper that describes the importance of using telemedicine to treat substance use disorders (SUD) during the COVID-19 pandemic. It discusses policy changes that have reduced barriers and provides recommendations on how to sustain implementation of telehealth into SUD treatment after the pandemic. 

This is a report from SAMHSA that reviews the literature on the effectiveness of telehealth modalities for the treatment of severe mental illness (SMI) and substance use disorder (SUD), distills the research into recommendations for practice, and provides examples of how practitioners use these practices in their programs.

This is an academic paper that presents promising findings from the HEROES program in Texas that reported an overall increase in patient engagement over time after rapidly enacted virtual care with telehealth for peer coaching, counseling, groups, and provider visits in response to the coronavirus pandemic. 

This is a CADTH Rapid Response Report that gives a critical appraisal on providing medications for opioid use disorder (MOUD) via telemedicine. The report summarizes the evidence for telehealth-delivered MOUD and provides evidence-based guidelines, a cost-effective analysis, and guidance on initiation of MOUD at home. 

This is a brief report from the US Dept. of Health and Human Services that provides clinical scenario examples that are compliant with current DEA policies around using telehealth to deliver medications for opioid use disorder (MOUD). 

This is an academic paper that provides commentary on leveraging telehealth to increase the capacity of medications for opioid use disorder (OUD). Current evidence, existing state laws, barriers, and policy recommendations are discussed. 

This is an academic paper that provides commentary on the importance of telemedicine as a tool to address the opioid crisis. Applying telehealth to delivering medications for opioid use disorder (MOUD) has the potential to overcome barriers that keep people with opioid use disorder (OUD) from seeking treatment. 

This is a report from the Police Executive Research Forum, which convened public safety and public health experts to provide recommendations as standards of care for police departments in addressing the opioid crisis. Additionally, successfully implemented models are highlighted in this document. 

This is a report from the Center for Court Innovation and reflects the cumulative effort of a working group of more than more than thirty criminal justice system practitioners, subject matter experts, researchers, and government officials. The history of opioid intervention courts are discussed and ten essential elements are made that all opioid intervention courts should strive for. 

This is commentary from the New England Journal of Medicine that gives an overview of the evidence for initiating medications in the emergency department for opioid use disorder and highlights the importance of scaling this beneficial intervention given the increasing overdoses during the coronavirus pandemic. 

This is a report from the National Academy of Medicine that describes the impact of the opioid crisis and promising approaches for five specific subpopulations: justice-involved populations, rural populations, veterans, adolescents and young adults, and persons who inject drugs.

This is an academic article from an expert in adolescent treatment of opioid use disorder that discusses the results of a previous trial of youth and young adults randomized to either extended-release naltrexone or buprenorphine. Outcomes were worse in youth, and this commentary discusses the problems of the treatment system for this population.